Novel signal transduction modulators for the treatment of airway diseases

This publication has 74 references indexed in Scilit:

• Decreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary Disease
  New England Journal of Medicine, 2005
• Targeting Syk as a treatment for allergic and autoimmune disorders
  Expert Opinion on Investigational Drugs, 2004
• The Toxicity of SCH 351591, a Novel Phosphodiesterase-4 Inhibitor, in Cynomolgus Monkeys
  Toxicologic Pathology, 2004
• Inhibitors of Protein Kinase C (PKC) Prevent Activated Transcription
  Journal of Biological Chemistry, 2004
• p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases
  Nature Reviews Drug Discovery, 2003
• Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations
  Thorax, 2003
• Increased expression of nuclear factor-κB in bronchial biopsies from smokers and patients with COPD
  European Respiratory Journal, 2002
• Cyclic nucleotide phosphodiesterases
  Journal of Allergy and Clinical Immunology, 2001
• Activation and Localization of Transcription Factor, Nuclear Factor- κ B, in Asthma
  American Journal of Respiratory and Critical Care Medicine, 1998
• Src family‐selective tyrosine kinase inhibitor, PP1, inhibits both FcεRI‐ and Thy‐1‐mediated activation of rat basophilic leukemia cells
  European Journal of Immunology, 1997